OPIANT PHARMACEUTICALS, INC. Quarterly Revenues in USD from Q3 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Revenues history and growth rate from Q3 2010 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Revenues for the quarter ending September 30, 2022 was $174K, a 98.9% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. Revenues for the twelve months ending September 30, 2022 was $22.3M, a 49.1% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Revenues for 2021 was $47.8M, a 61.3% increase from 2020.
  • Opiant Pharmaceuticals, Inc. annual Revenues for 2020 was $29.6M.
  • Opiant Pharmaceuticals, Inc. annual Revenues for 2018 was $14M, a 10.1% decline from 2017.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $22.3M $174K -$16.2M -98.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $38.5M $3.89M -$7.37M -65.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $45.9M $4.47M -$1.92M -30% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $47.8M $13.8M +$3.88M +39.1% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 $43.9M $16.3M +$7.23M +79.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $36.7M $11.3M +$4.95M +78.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $31.7M $6.39M +$2.1M +49.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $29.6M $9.92M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $9.11M -$11.5M -55.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $6.31M -$461K -6.81% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $4.28M -$1.15M -21.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $37.6M $20.6M +$16.3M +373% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $21.3M $6.77M +$3.62M +115% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $17.7M $5.44M +$3.73M +219% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $14M $4.76M -$6.98M -59.5% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-21
Q3 2018 $21M $4.37M +$4.34M +19745% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $16.6M $3.15M -$622K -16.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $17.2M $1.7M +$1.69M +15382% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $15.6M $11.7M -$1.79M -13.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $17.3M $22K -$1.1M -98% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $18.4M $3.77M +$3.46M +1107% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $15M $11K -$2.59M -99.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $17.6M $13.5M +$6.68M +97.3% Nov 1, 2016 Jan 31, 2017 10-Q 2017-03-15
Q3 2016 $10.9M $1.12M +$1M +834% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-04
Q2 2016 $9.9M $312K -$558K -64.1% May 1, 2016 Jul 31, 2016 10-KT 2018-03-07
Q1 2016 $10.5M $2.61M +$2.49M +2071% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 $7.97M $6.86M +$6.3M +1125% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-15
Q3 2015 $1.67M $120K +$120K Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-15
Q2 2015 $1.55M $870K May 1, 2015 Jul 31, 2015 10-K 2016-10-28
Q1 2015 $120K Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 $560K Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-15
Q3 2014 $0 Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-14
Q4 2012 $0 $0 $0 Nov 1, 2012 Jan 31, 2013 10-Q 2013-03-18
Q3 2012 $0 $0 $0 Aug 1, 2012 Oct 31, 2012 10-Q 2012-12-20
Q2 2012 $0 $0 $0 May 1, 2012 Jul 31, 2012 10-K/A 2012-11-01
Q1 2012 $0 $0 $0 Feb 1, 2012 Apr 30, 2012 10-Q 2012-06-14
Q4 2011 $0 $0 $0 Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $0 $0 $0 Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
Q2 2011 $0 $0 May 1, 2011 Jul 31, 2011 10-K/A 2012-11-01
Q1 2011 $0 Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 $0 Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q3 2010 $0 Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.